Telix – Talk Bio

Genentech’s $700M North Carolina Plant and Telix’s FDA CRL Update

2 weeks ago talkbio0Tagged biomanufacturing, Complete Response Letter, CRL, genentech, Holly Springs, Manufacturing Facilities, Medicinal product acting as imaging agent (product), metabolic medicines, North Carolina, Obesity, Roche (company), Telix, United States Food and Drug Administration

Genentech; Roche; North Carolina; manufacturing facility; $700 million; Holly Springs; metabolic medicines; obesity treatments; biomanufacturing; Telix; FDA; Complete Response Letter (CRL); imaging agent

Telix Acquires RLS to Bolster Radiopharmaceutical Manufacturing and Distribution in North America

12 months ago talkbio0Tagged Acquisition (action), North America, production, radiometal, Radiopharmaceuticals, Restless Legs Syndrome, Social Networks, Spatial Distribution, Telix

Telix Pharmaceuticals, RLS (USA) Inc., radiopharmaceutical manufacturing, distribution, acquisition, North America, radiometal production network

Telix Pharmaceuticals Raises $400M in Bond Sale Amid IPO Uncertainty

1 year ago talkbio0Tagged bond sale, IPO, Radiopharma, Telix

Telix Pharmaceuticals, Bond Sale, IPO, Radiopharma, Funding

Telix Pharmaceuticals Aims for $200 Million IPO in Radiopharmaceuticals Market Amid Slowing Biotech Nasdaq Offerings

1 year ago talkbio0Tagged biotech, IPO, Nasdaq, offerings, Radiopharmaceuticals, Telix

Telix Pharmaceuticals, Radiopharmaceuticals, IPO, Biotech, Nasdaq Offerings